PQA Annual Meeting - Pharmacy Quality Alliance Annual Meeting

Even before the COVID-19 pandemic, vaccine hesitancy has been a challenge among adult patient populations.

Pharmacists are well suited to help patients overcome the barriers that prevent access to therapy regimens.

It is essential to change the way pharmacists address the needs of diverse populations.

Awards honor excellence and improvement in overall CMS Medicare Star Ratings and PQA Medication Measures.

Open to all health care professionals, the PQA meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care and quality improvement initiatives.

Patient engagement programs should continually evolve in order to meet patient needs and behaviors.

With the creation of a diabetes prevention program, participants are able to make lasting behavioral changes, such as eating healthier, increasing physical activity, and improving problem-solving skills.

High engagement and collaboration between health systems and health plans is essential to implementing value-based models, according to a session at the Pharmacy Quality Alliance 2021 Annual Conference.

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

Awards honor an individual and community pharmacy for innovative, pioneering practices.

Pharmacists interact with patients more than any other member of the health care team, therefore it is vital they help address barriers and gaps in member care that impact plan performance.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

Further integration with care teams and using data to demonstrate the value of pharmacists will be essential to maintaining the momentum created by the COVID-19 pandemic.

Open to all health care professionals, the PQA meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care, and quality improvement initiatives.

At the first educational session of PQA, the speakers discussed pharmacists’ roles in influencing outcomes associated with social determinants of health in the US population.

Before COVID-19, the health care industry was largely headed toward a value-based system that was shifting to focus on social determinants of health, according to Bruce Japsen, at the PQA 2020 Annual Meeting.

Primary care will require a focus on individual and community health in the post coronavirus disease 2019 (COVID-19) era, according to a session presented on Thursday during the Pharmacy Quality Alliance (PQA) 2020 Annual Meeting.

Awards honor an individual and community pharmacy for innovative and pioneering practices.

Medication therapy problem category framework is the tool used to collect and evaluate medication-related issues

The impact of COVID-19 on pharmacy has been significant in the short-term, and recent developments have shown that there is opportunity for that to translate into long-term changes for the industry.

At the PQA 2020 Annual Meeting on Thursday, speakers discussed some of the drivers of medication adherence in community pharmacy.

Awards honor excellence and improvements in overall star ratings and PQA medication measures.

Pharmacy Quality Solutions Annual Trend Report focuses on questions around consumer perceptions and behaviors.

In order to curb the opioid epidemic among employees, companies need to begin by identifying who is at risk.

Matthew Pickering, PharmD, RPh, PQA Senior Director of Research & Quality Strategies at Pharmacy Quality Alliance discusses what pharmacists bring to patient care in the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Matthew Pickering, PharmD, RPh, PQA Senior Director of Research & Quality Strategies at Pharmacy Quality Alliance discusses its medication access framework for quality measurement during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

Laura Cranston, RpH, CEO of Pharmacy Quality Alliance (PQA), discusses the organization's origins as a measure developer during the PQA Annual Meeting in Baltimore, MD.

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses PQA's new opioid measures and how they complement existing measures during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.

PQA is described as a "a neutral convener of a multistakeholder base."

Norris Turner, PharmD, PhD, vice president of Strategic Alliances and Measures at PQA discusses the uses of PQA's measures in Medicaid during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.